Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 105 Pages
Report ld: 6088531
Request Sample
Customized Report
Hyperoside Market Size(US$)

CAGR 2026-2032
5.3%
Market Size,2032
USD 189
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hyperoside was estimated to be worth US$ 132 million in 2025 and is projected to reach US$ 189 million, growing at a CAGR of 5.3% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hyperoside cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hyperoside is a natural flavonol glycoside compound with the chemical name of quercetin-3-O-galactoside, which is widely found in many plants. It has biological activities such as antioxidant, anti-inflammatory, antiviral, cardiovascular protection and neuroprotection, and is often used in the fields of medicine, health products and functional foods.
The North American market for Hyperoside was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Hyperoside was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Hyperoside was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Hyperoside market include FUJIFILM Wako Pure Chemical Corporation, Simson Pharma, ChemFaces, Chemodex, Extrasynthese, Merck Group, Otto kemi, Tokyo Chemical Industry, ChemScene, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Hyperoside, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hyperoside market size, estimations, and forecasts are presented in terms of sales volume (kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hyperoside.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hyperoside manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hyperoside sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hyperoside sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hyperoside Product Introduction
1.2 Global Hyperoside Market Size Forecast
1.2.1 Global Hyperoside Sales Value (2021–2032)
1.2.2 Global Hyperoside Sales Volume (2021–2032)
1.2.3 Global Hyperoside Sales Price (2021–2032)
1.3 Hyperoside Market Trends & Drivers
1.3.1 Hyperoside Industry Trends
1.3.2 Hyperoside Market Drivers & Opportunities
1.3.3 Hyperoside Market Challenges
1.3.4 Hyperoside Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hyperoside Players Revenue Ranking (2025)
2.2 Global Hyperoside Revenue by Company (2021–2026)
2.3 Global Hyperoside Sales Volume Ranking of Players (2025)
2.4 Global Hyperoside Sales Volume by Company (2021–2026)
2.5 Global Hyperoside Average Price by Company (2021–2026)
2.6 Key Manufacturers Hyperoside Manufacturing Base and Headquarters
2.7 Key Manufacturers Hyperoside Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hyperoside
2.9 Hyperoside Market Competitive Analysis
2.9.1 Hyperoside Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hyperoside Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hyperoside revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hyperoside Market Classification
3.1 Introduction by Type
3.1.1 97%-98%
3.1.2 98%-99%
3.1.3 >99%
3.1.4 Global Hyperoside Sales Value by Type
3.1.4.1 Global Hyperoside Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Hyperoside Sales Value, by Type (2021–2032)
3.1.4.3 Global Hyperoside Sales Value, by Type (%), 2021–2032
3.1.5 Global Hyperoside Sales Volume by Type
3.1.5.1 Global Hyperoside Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Hyperoside Sales Volume, by Type (2021–2032)
3.1.5.3 Global Hyperoside Sales Volume, by Type (%), 2021–2032
3.1.6 Global Hyperoside Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cosmetics
4.1.2 Food
4.1.3 Drugs
4.1.4 Others
4.2 Global Hyperoside Sales Value by Application
4.2.1 Global Hyperoside Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hyperoside Sales Value, by Application (2021–2032)
4.2.3 Global Hyperoside Sales Value, by Application (%), 2021–2032
4.3 Global Hyperoside Sales Volume by Application
4.3.1 Global Hyperoside Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hyperoside Sales Volume, by Application (2021–2032)
4.3.3 Global Hyperoside Sales Volume, by Application (%), 2021–2032
4.4 Global Hyperoside Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hyperoside Sales Value by Region
5.1.1 Global Hyperoside Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hyperoside Sales Value by Region (2021–2026)
5.1.3 Global Hyperoside Sales Value by Region (2027–2032)
5.1.4 Global Hyperoside Sales Value by Region (%), 2021–2032
5.2 Global Hyperoside Sales Volume by Region
5.2.1 Global Hyperoside Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hyperoside Sales Volume by Region (2021–2026)
5.2.3 Global Hyperoside Sales Volume by Region (2027–2032)
5.2.4 Global Hyperoside Sales Volume by Region (%), 2021–2032
5.3 Global Hyperoside Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hyperoside Sales Value, 2021–2032
5.4.2 North America Hyperoside Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hyperoside Sales Value, 2021–2032
5.5.2 Europe Hyperoside Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hyperoside Sales Value, 2021–2032
5.6.2 Asia Pacific Hyperoside Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hyperoside Sales Value, 2021–2032
5.7.2 South America Hyperoside Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hyperoside Sales Value, 2021–2032
5.8.2 Middle East & Africa Hyperoside Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hyperoside Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hyperoside Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hyperoside Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hyperoside Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hyperoside Sales Value, 2021–2032
6.3.2 United States Hyperoside Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hyperoside Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hyperoside Sales Value, 2021–2032
6.4.2 Europe Hyperoside Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hyperoside Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hyperoside Sales Value, 2021–2032
6.5.2 China Hyperoside Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hyperoside Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hyperoside Sales Value, 2021–2032
6.6.2 Japan Hyperoside Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hyperoside Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hyperoside Sales Value, 2021–2032
6.7.2 South Korea Hyperoside Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hyperoside Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hyperoside Sales Value, 2021–2032
6.8.2 Southeast Asia Hyperoside Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hyperoside Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hyperoside Sales Value, 2021–2032
6.9.2 India Hyperoside Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hyperoside Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 FUJIFILM Wako Pure Chemical Corporation
7.1.1 FUJIFILM Wako Pure Chemical Corporation Company Information
7.1.2 FUJIFILM Wako Pure Chemical Corporation Introduction and Business Overview
7.1.3 FUJIFILM Wako Pure Chemical Corporation Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 FUJIFILM Wako Pure Chemical Corporation Hyperoside Product Offerings
7.1.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
7.2 Simson Pharma
7.2.1 Simson Pharma Company Information
7.2.2 Simson Pharma Introduction and Business Overview
7.2.3 Simson Pharma Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Simson Pharma Hyperoside Product Offerings
7.2.5 Simson Pharma Recent Developments
7.3 ChemFaces
7.3.1 ChemFaces Company Information
7.3.2 ChemFaces Introduction and Business Overview
7.3.3 ChemFaces Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 ChemFaces Hyperoside Product Offerings
7.3.5 ChemFaces Recent Developments
7.4 Chemodex
7.4.1 Chemodex Company Information
7.4.2 Chemodex Introduction and Business Overview
7.4.3 Chemodex Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Chemodex Hyperoside Product Offerings
7.4.5 Chemodex Recent Developments
7.5 Extrasynthese
7.5.1 Extrasynthese Company Information
7.5.2 Extrasynthese Introduction and Business Overview
7.5.3 Extrasynthese Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Extrasynthese Hyperoside Product Offerings
7.5.5 Extrasynthese Recent Developments
7.6 Merck Group
7.6.1 Merck Group Company Information
7.6.2 Merck Group Introduction and Business Overview
7.6.3 Merck Group Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Merck Group Hyperoside Product Offerings
7.6.5 Merck Group Recent Developments
7.7 Otto kemi
7.7.1 Otto kemi Company Information
7.7.2 Otto kemi Introduction and Business Overview
7.7.3 Otto kemi Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Otto kemi Hyperoside Product Offerings
7.7.5 Otto kemi Recent Developments
7.8 Tokyo Chemical Industry
7.8.1 Tokyo Chemical Industry Company Information
7.8.2 Tokyo Chemical Industry Introduction and Business Overview
7.8.3 Tokyo Chemical Industry Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Tokyo Chemical Industry Hyperoside Product Offerings
7.8.5 Tokyo Chemical Industry Recent Developments
7.9 ChemScene
7.9.1 ChemScene Company Information
7.9.2 ChemScene Introduction and Business Overview
7.9.3 ChemScene Hyperoside Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 ChemScene Hyperoside Product Offerings
7.9.5 ChemScene Recent Developments
8 Industry Chain Analysis
8.1 Hyperoside Industrial Chain
8.2 Hyperoside Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hyperoside Sales Model
8.5.2 Sales Channels
8.5.3 Hyperoside Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hyperoside market is projected to grow from US$ 132 million in 2025 to US$ 189 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 143
USD 4900.00
(Single User License)
The global Hyperoside market size was US$ 132 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 76
USD 4250.00
(Single User License)
The global Hyperoside market was valued at US$ 132 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 129
USD 2900.00
(Single User License)
The global market for Hyperoside was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 180 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-07-03
Pages: 92
USD 2900.00
(Single User License)
The global Hyperoside market is projected to grow from US$ 132 million in 2025 to US$ 180 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published Date: 2025-07-03
Pages: 148
USD 4900.00
(Single User License)
The global Hyperoside market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 180 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-07-03
Pages: 76
USD 4250.00
(Single User License)
The global market for Hyperoside was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 180 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-07-03
Pages: 96
USD 3950.00
(Single User License)
The global Hyperoside market is projected to grow from US$ 132 million in 2025 to US$ 189 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 143
The global Hyperoside market size was US$ 132 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 76
The global Hyperoside market was valued at US$ 132 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-12
Pages: 129
The global market for Hyperoside was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 180 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-07-03
Pages: 92
The global Hyperoside market is projected to grow from US$ 132 million in 2025 to US$ 180 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published: 2025-07-03
Pages: 148
The global Hyperoside market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 180 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-07-03
Pages: 76
The global market for Hyperoside was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 180 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-07-03
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now